Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC

BSE727.107.55 (+1.05 %)

PREV CLOSE ( ) 719.55

OPEN PRICE ( ) 726.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 546

TODAY'S LOW / HIGH ( )714.00 734.70

52 WK LOW / HIGH ( )555.85 1053.05

NSE725.755.4 (+0.75 %)

PREV CLOSE( ) 720.35

OPEN PRICE ( ) 724.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 725.75 (22)

VOLUME 22800

TODAY'S LOW / HIGH( ) 710.00 735.30

52 WK LOW / HIGH ( )554.1 1055

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-01 2000

Management Info

- Chairman Rahul Guha - Managing Director

Registered Office

Address D - 37/1, T T C Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone 022 3090 0000 / 2762 2762

Email compliance@thyrocare.com

Website www.thyrocare.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

04Dec Thyrocare Technologies makes another e
Thyrocare Technologies has made another tranche of equity investment of..

04Dec Thyrocare Technologies gains on making
Thyrocare Technologies is currently trading at Rs. 1027.10, up by 13.65..

30Aug Thyrocare Technologies informs about e
Thyrocare Technologies has informed that the Company has entered into Bu..

30Jul Thyrocare Technologies acquires busine
Thyrocare Technologies has completed the acquisition of the diagnostic a..

25Jun Thyrocare Technologies informs about d
Thyrocare Technologies has informed that it enclosed Disclosures of reas..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	191	711.4
Gross Profit	279.4	982.2
Operating Profit	437.6	1410.6
Net Sales	1525.5	5240.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Vijaya Diagnostic (BSE) 993.70 (7.43%)	M.Cap ( in Cr)10198.97
Global Health (BSE) 1234.60 (2.35%)	M.Cap ( in Cr)33159.80
RainbowChildrenS Med (BSE) 1319.95 (1.48%)	M.Cap ( in Cr)13404.31
Fortis Healthcare (BSE) 618.75 (1.51%)	M.Cap ( in Cr)46713.04
Kovai Medical Center (BSE) 6132.55 (0.10%)	M.Cap ( in Cr)6710.40

Shareholding Pattern

	PROMOTERS	71.06%
	MUTUAL FUNDS/UTI	12.75%
	NON-INSTITUTION	11.5%
	FI/BANKS/INSURANCE	1.06%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	1.81
ICICI Pru Pharma He...	1.30
Quant Small Cap Fund(G)	0.36
Nippon India Small ...	0.29
ICICI Pru India Opp...	0.26
Bandhan BSE Healthc...	0.11
Motilal Oswal BSE H...	0.11

Risk Disclosures on Derivatives

Smart Quotes

THYROCARE TECHNOLOGIES LTD.